2.51 USD
↗ 0.04 (1.78%)PRE MARKET (AS OF 07:01 AM EDT)
Genelux Corporation Common Stock
GNLXNASDAQ • USD
Market: OPEN
GNLX is currently priced at $2.51. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, GNLX is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Sep 15, 2026.
Open?$2.51
High?$2.51
Low?$2.51
Prev. Close?$2.47
Volume?44
Avg. Volume?359.5K
VWAP?$2.51
Rel. Volume?0.00x
Bid / Ask
Bid?$2.11 × 100
Ask?$2.92 × 100
Spread?$0.81
Midpoint?$2.51
Valuation & Ratios
Market Cap?111.8M
Shares Out?45.2M
Float?38.2M
Float %?85.3%
P/E Ratio?N/A
P/B Ratio?6.94
EPS?-$0.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Themes
Employees
26
Market Cap
114.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-01-26
Address
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE, CA 91361
Phone: 805-267-9889
WESTLAKE VILLAGE, CA 91361
Phone: 805-267-9889
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?23
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.56Distress
Confidence?64%Moderate
Short InterestVery High
Short % of Float?9.88%Elevated
Short Interest?3.8M
Days to Cover?10.7
Free Float38.2M
Avg Daily Volume354.6K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.39Strong
Quick Ratio?2.39Strong
Cash Ratio?1.15Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?6.94FAIR▾
Peers100
S&P27
P/S?13,969.50HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.8CHEAP▾
S&P97
EV/Sales?12,821.50HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-220.9%WEAK▾
S&P3
ROA?-135.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28683000
Enterprise Value?$102.6M
Fundamentals ratios updated end of day